Modelling and simulation of experimental designs to find the best design of randomized clinical trials in a rare disease: Cystic fibrosis
Conclusion: This in silico approach could be used to find the most effective clinical trial design, especially in rare diseases such as CF.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Kurbatova, P., Bajard, A., Tiddens, H., Volpert, V., Cornu, C., Bessonov, N., Kassai, B., Chabaud, S., Nony, P., Caudri, D. Tags: 7.3 Cystic Fibrosis Source Type: research
More News: Clinical Trials | Cystic Fibrosis | Pulmozyme | Rare Diseases | Respiratory Medicine | Statistics